METASTATIC SINONASAL UNDIFFERENTIATED CARCINOMA

Clinical trials for METASTATIC SINONASAL UNDIFFERENTIATED CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new METASTATIC SINONASAL UNDIFFERENTIATED CARCINOMA trials appear

Sign up with your email to follow new studies for METASTATIC SINONASAL UNDIFFERENTIATED CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Targeted pill tested for Hard-to-Treat head cancers

Disease control Recruiting now

This study is testing whether a daily pill called enasidenib can help control rare cancers in the nasal cavity and base of the skull. It is for adults whose cancer has a specific genetic change (IDH2 mutation) and has returned or spread after prior treatment. The goal is to see i…

Matched conditions: METASTATIC SINONASAL UNDIFFERENTIATED CARCINOMA

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

METASTATIC SINONASAL UNDIFFERENTIATED CARCINOMA

Get alerted when new METASTATIC SINONASAL UNDIFFERENTIATED CARCINOMA trials appear

Targeted pill tested for Hard-to-Treat head cancers